GeneDx Holdings Corp.
WGS· Nasdaq
WGSGeneDx Holdings Corp.
Filed Nov 14, 2022 · 10-Q · 45 days after period end · 0001818331-22-000078
| Metric | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|
| Revenue | $83.23M | $43.18M | $38.61M |
| Net Income | -$77.58M | $32.73M | -$56.62M |
| EPS Diluted | -$6.72 | $0.16 | -$456,573.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GeneDx Holdings Corp. · CIK 1818331 · Engraved from SEC EDGAR
ended Sep 30, 2022 · filed Nov 14, 2022 · 45 d after period end
